Can't do the math without knowing the royalty rates, I hope they are higher than in the past.
Announced. I am assuming they are getting better royalty rates on these newer deals. Rates were quite bad on the early deals.
With Baxter, Roche, Pfizer , JNJ and now Abbvie, can Amgen be far behind?
I continue to have faith based upon the large insider ownership and the fact that these guys are not young, and are not selling.
I am out as well at least for the time being. Brazil is the issue. Took some nice profits and bought BRKB with them.
AM Best should provide their annual review of NWLI shortly (usually has been in May or June). They may comment on Brazil.
If the Brazil issue is totally cleared, I would consider buying back in.